Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer's disease
Chronic cytoprotection: Pentadecapeptide BPC 157, ranitidine and propranolol prevent, attenuate and reverse the gastric lesions appearance in chronic alcohol drinking rats
Studies show the peptide stimulates secretion of vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) from hair follicle cells, with experimental formulations producing the most significant increases in these growth factors
BPC-157 Human Clinical Trials Status (2025-2026) Only 3 published human studies exist as of March 2026all pilot studies with small sample sizes The largest trial was cancelled : A 2015 Phase I study with 42 volunteers never published results Total human subjects studied : Fewer than 30 people across all published trials No randomized controlled trials : All existing studies lack placebo controls What the Human Studies Show Interstitial cystitis (2024) : 12 patients, 80-100% symptom resolution with bladder injections Knee pain (2021) : 16 patients, 87.5% reported significant relief at 6-12 months IV safety (2025) : 2 adults tolerated up to 20mg IV with no adverse effects Regulatory Reality FDA Category 2 (2023): Cannot be legally compounded due to insufficient safety data WADA prohibited (2022): Banned under S0 Unapproved Substances for all athletes Not approved anywhere : No regulatory agency worldwide has approved BPC-157 for human use The Gap Between Animal and Human Research If youve read about BPC-157 online, youve likely encountered impressive claims: accelerated tendon healing, gut repair, nerve regeneration, and more
Identification of a mutation in SLC30A2 (ZnT-2) in women with low milk zinc concentration that results in transient neonatal zinc deficiency
The Transcend Micro 510 Portable Auto CPAP is designed for patients who want to maintain effective sleep apnea treatment while away from home
%20(1).png)
